Skip to main content
. Author manuscript; available in PMC: 2022 Nov 30.
Published in final edited form as: Subst Use Misuse. 2022 Apr 21;57(7):1144–1153. doi: 10.1080/10826084.2022.2064509

Table 2.

Summary of MOUD Treatment Themes

POSITIVE CHANGES
Medication Take
Homes and Deliveries
Most participants found increased medication take home doses and newly initiated deliveries to be a favorable change
  • Found less in-person MOUD program contact to be a positive change
  • Allowed for a better life balance
Telehealth Most participants found telehealth to be a favorable change
  • Found less in-person MOUD program contact to be a positive change
  • Allowed for providers to reach underserved communities in rural and other difficult locations
CHALLENGES
Medication Take
Homes and Deliveries
A few participants noted decreased access to basic goods that they were able to previously obtain via in-person visits at some MOUD clinics
Telehealth A few participants noted decreased access to basic goods that they were able to previously obtain via in-person visits at some MOUD clinics
Clinic Closures,
Reduced Capacity, and
Clinic Transfers
Most participants described clinics not being able to operate at full capacity
  • Mostly buprenorphine prescribers discussed clinic closures while methadone staff/clients discussed clinics reducing capacity
Social Distancing Instituted to prevent/reduce COVID-19 spread, some participants noted challenges of
  • Inability of clinics to enforce social distancing protocols
  • Long lines outside clinics which could increase visibility and stigma